GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » YoY EBITDA Growth

Grand Brilliance Group Holdings (HKSE:08372) YoY EBITDA Growth : 50.00% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Grand Brilliance Group Holdings's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 50.00%.

Grand Brilliance Group Holdings's EBITDA per Share for the three months ended in Sep. 2023 was HK$0.00.


Grand Brilliance Group Holdings YoY EBITDA Growth Historical Data

The historical data trend for Grand Brilliance Group Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings YoY EBITDA Growth Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial - 63.64 -11.11 -25.00 41.67

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.00 -25.00 600.00 - 50.00

Grand Brilliance Group Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Grand Brilliance Group Holdings's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(0.017-0.012)/ | 0.012 |
=41.67 %

Grand Brilliance Group Holdings's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(0.003-0.002)/ | 0.002 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grand Brilliance Group Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Executives
Miu Yin Shun Andrew 2202 Interest of your spouse
Wong Bik Kwan Bikie 2101 Beneficial owner
B&a Success Limited 2101 Beneficial owner

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines